ADMA Biologics annual meeting results: all proposals pass including election of two Class I directors

ADMA BIOLOGICS, INC.

Alison C. Finger elected as Class I director with 156.8M for, 19.4M withheld, 23.0M broker non-votes.
Eduardo Rene Salas elected with 172.0M for, 4.3M withheld, 23.0M broker non-votes.
Ratification of KPMG as auditor for FY2026 approved: 198.7M for, 0.33M against, 0.28M abstain.
Non-binding Say-on-Pay proposal approved with 168.2M for, 7.7M against, 0.33M abstain, 23.0M broker non-votes.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ADMA BIOLOGICS, INC. shareholders approved Election of two nominees to serve as Class I directors until the Company's 2029 Annual Meeting of Stockholders and until such director's successor is duly elected and qualified, or such director's earlier resignation, removal or death at the 2026-06-02 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-02

Exact text from the filing

Proposal No. 1 — Election of the Class I Directors The vote with respect to the election of each of the directors was as follows: Nominee For Withheld Broker Non-Votes Alison C. Finger 156,849,830 19,376,842 23,040,875 Eduardo Rene Salas 171,947,523 Shares 4,279,149 Shares 23,040,875 Shares

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ADMA BIOLOGICS, INC. shareholders approved Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers at the 2026-06-02 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-02

Exact text from the filing

Proposal No. 3 — Approval of the Say-on-Pay Proposal The vote with respect to the approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers was as follows: For Against Abstain Broker Non-Votes 168,169,866 Shares 7,730,690 Shares 326,116 Shares 23,040,875 Shares

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ADMA BIOLOGICS, INC. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-02 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-02

Exact text from the filing

Proposal No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was as follows: For Against Abstain 198,655,040 Shares 329,056 Shares 283,451 Shares

View on SEC.gov

303 shareholder votes filed in the last 30 days. Browse all shareholder votes →

ADMA BIOLOGICS, INC. filing history →

Source: SEC EDGAR

accession 0001140361-26-023705

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.